MapLight Therapeutics, Inc. (MPLT)
13.12
+0.15
(+1.16%)
USD |
NASDAQ |
Sep 01, 11:38
MapLight Therapeutics Cash from Operations (TTM) : -174.67M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -174.67M |
| March 31, 2026 | -163.76M |
| December 31, 2025 | -138.14M |
| Date | Value |
|---|---|
| September 30, 2025 | -108.84M |
| June 30, 2025 | -96.99M |
| March 31, 2025 | -75.01M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Evommune, Inc. | -74.15M |
| Sarepta Therapeutics, Inc. | 93.95M |
| Cullinan Therapeutics, Inc. | -159.25M |
| Mineralys Therapeutics, Inc. | -138.79M |
| Apogee Therapeutics, Inc. | -243.89M |